Lonza AG
Lonza AG is a drug establishment in Stein AG, Switzerland, registered with the US FDA under FEI 3016502617. Its registered operations are: Analytical testing, Drug manufacture. 10 EU/UK GMP certificates are matched to this site, 4 inspected within the last three years.
Sources: FDA Drug Establishments Current Registration Site (checked 2 Nov 2026); EudraGMDP; MHRA GMDP. Methodology
Registered operations
Business operations this establishment declares in its FDA registration. Registration is not an approval and says nothing about EU or UK GMP status.
GMP documents matched to this site (10)
| Document | Authority | Inspection | Source |
|---|---|---|---|
GMPE-CH-1007960 GMP certificate | Competent authority of Switzerland | 9 Aug 2024 within 3-year review window | EudraGMDP |
GMPE-CH-1007387 GMP certificate | Competent authority of Switzerland | 9 Aug 2024 within 3-year review window | EudraGMDP |
GMPE-CH-1007429 GMP certificate | Competent authority of Switzerland | 9 Aug 2024 within 3-year review window | EudraGMDP |
GMPE-CH-1007312 GMP certificate | Competent authority of Switzerland | 9 Aug 2024 within 3-year review window | EudraGMDP |
GMPE-CH-1006614 GMP certificate | Competent authority of Switzerland | 21 Jul 2022 outside 3-year review window | EudraGMDP |
GMPE-CH-1006220 GMP certificate | Competent authority of Switzerland | 21 Jul 2022 outside 3-year review window | EudraGMDP |
GMPE-CH-1005577 GMP certificate | Competent authority of Switzerland | 21 Jul 2022 outside 3-year review window | EudraGMDP |
GMPE-CH-1005945 GMP certificate | Competent authority of Switzerland | 21 Jul 2022 outside 3-year review window | EudraGMDP |
GMPE-CH-1006204 GMP certificate | Competent authority of Switzerland | 21 Jul 2022 outside 3-year review window | EudraGMDP |
GMPE-CH-1005615 GMP certificate | Competent authority of Switzerland | 21 Jul 2022 outside 3-year review window | EudraGMDP |
A GMP document is matched to this site when its address names the site's street and its city or postcode. In our latest internal review 59 of 60 sampled matches were the right site (not yet independently reviewed; measured match quality). Check the certificate's own address before relying on it. The three-year review window is the EMA guideline default after an inspection, not an official expiry date.
What this page does not show
- Which substances are made here: DMFs and CEPs are filed by organisations, not sites, so we do not link substances to this site.
- Capacity, scale, price or current availability: no regulator publishes these.
- FDA inspection classifications for this site, which are not yet linked.
Other sites registered by the same company
- Lonza AGVisp, Switzerland · API manufacture
- Lonza AGBasel, Switzerland
- Lonza AGVisp, Switzerland · API manufacture
- Lonza Biologics Porrino SLO PORRI�O, Spain · API manufacture
- LONZA BIOLOGICS TUAS PTE. LTD.Singapore, Singapore · API manufacture
- Lonza Biologics, Inc.Portsmouth, United States · API manufacture
- Lonza Biologics, plcSlough, United Kingdom · API manufacture
- Lonza Guangzhou Pharmaceutical Ltd.Guangzhou, China · API manufacture
- Lonza Houston, IncHouston, United States · API manufacture
- Lonza Manufacturing LLCVacaville, United States · API manufacture
- Lonza Netherlands B.V.Geleen, Netherlands